TISSUEGEN FOUNDER AND CSO DR. KEVIN NELSON TO PRESENT “PHARMACEUTICALS AND BIOLOGICS DELIVERY FROM BIODEGRADABLE FIBER” SESSION AT IFAI’S ADVANCED TEXTILES EXPO

12 Sep TISSUEGEN FOUNDER AND CSO DR. KEVIN NELSON TO PRESENT “PHARMACEUTICALS AND BIOLOGICS DELIVERY FROM BIODEGRADABLE FIBER” SESSION AT IFAI’S ADVANCED TEXTILES EXPO

WHO: TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to develop fiber and textile medical devices for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedic devices and sutures.

WHAT: Dr. Kevin Nelson, TissueGen Inc.’s Founder and CSO, will be presenting on the latest advancements in extrusion technology which are enabling the next generation of drug delivery at IFAI’s Advanced Textiles Expo.

At IFAI’s Advanced Textiles Expo, Dr. Nelson will discuss how the medical device industry has undergone a significant evolution over the past several years—with drug delivery moving to the forefront. The emergence of new extrusion methods that occur at or below body temperature are enabling drug-loading of a wider range of pharmaceutical and biological agents than ever before possible for use in biodegradable implantable devices for localized drug delivery within the body. The incorporation of these drug-loaded fibers into new or existing medical devices can result in faster healing, improved patient compliance, and lower negative outcomes at relatively low cost.

To set up a meeting, please contact Christopher Knowles at cknowles@tissuegen.com or 1.214.351.1922.

WHEN: Dr. Nelson’s presentation will take place on September 26th at 3:15 pm CST. The IFAI Expo will take place September 26-29, 2017.

WHERE:
Ernest N. Morial Convention Center
900 Convention Center Blvd
111 West Harbor Drive
New Orleans, LA 70130

To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or 1.401.490.9700.

About TissueGen
TissueGen® Inc. is the developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant. By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes. For more information, please visit www.tissuegen.com.

# # #

For more information contact:
Jordan Bouclin
SVM Public Relations
1.401.490.9700
jordan.bouclin@svmpr.com

No Comments

Sorry, the comment form is closed at this time.